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Abstract
Background: The broad topic of research ethics is one which has been relatively well-investigated
and discussed. Unique ethical issues have been identified for such populations as pediatrics, where
the issues of consent and assent have received much attention, and obstetrics, with concerns such
as the potential for research to cause harm to the fetus. However, little has been written about
ethical concerns which are relatively unique to the population of patients seen by the practitioner
of rehabilitation medicine.
Discussion: This paper reviews unique ethical concerns in conducting research in this population,
including decision-making capacity, communication, the potential for subject overuse, the timing of
recruitment, hope for a cure and therapeutic misconception and the nature of the health care
provider-research subject relationship.
Summary: Researchers in the area of rehabilitation medicine should be aware of some of the
unique ethical challenges posed by this patient population and should take steps to address any
potential concerns in order to optimize subject safety and ensure that studies meet current ethical
guidelines and standards.
Background
In each medical specialty, there are various patient charac-
teristics that have the potential to present unique ethical
and practical challenges in conducting research in that
specialty. In pediatrics, the issues might include such
things as patient age precluding truly informed consent,
substitute decision making by the parents, or the issue of
patient assent versus consent [1]. In obstetrics research,
one must carefully consider potential benefits and harms
to the fetus while respecting the rights and wishes of the
mother [2–4]. In medical genetics, there are potential
implications of research results not only for the partici-
pant but also for family members and future progeny [5].
All these issues, and these particular patient populations,
have been extensively studied and discussed in the sub-
specialty and ethics literature. However, the subject of
unique issues in research ethics in the rehabilitation
patient population has not been investigated to any sig-
nificant degree. A literature search, conducted through the
use of Medline and Bioethicsline (please note that Bioeth-
icsline is now retired and replaced by NLM gateway at
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http://gateway.nlm.nih.gov) in this area revealed no arti-
cles or publications regarding this topic.
The objective of this paper is to identify and discuss cer-
tain issues which might be considered relatively unique to
rehabilitation medicine. These include decision-making
capacity (which includes both the concepts of capacity
and competency), communication and language, the
potential for overuse of individual research subjects, prob-
lems with the timing of subject recruitment, the hope for
a cure in certain patient populations and the nature of the
health care provider – research subject relationship in the
rehabilitation setting. Each will be discussed separately.
Discussion
Decision-making capacity
It is widely recognized that in order to consent to partici-
pate in a research protocol, three conditions must be met
[6] – patient capacity (the ability of the patient to under-
stand the nature of the research, as well as its risks and
benefits, in order to make an informed decision), volun-
tariness (freedom from undue coercion, be it deliberate or
unintended) and disclosure (the provision of all informa-
tion necessary for the potential subject to assist them in
the decision-making process).
There are many different types of patients and patient
diagnostic categories treated within the specialty of reha-
bilitation medicine. Some patients have isolated deficits
such as multiple fractures or spinal cord injuries with no
involvement of the brain or of cognitive function, and in
this case, decision-making capacity is generally not a sig-
nificant factor which needs to be considered in the process
of obtaining informed consent. However, a fairly large
proportion of patients seen by rehabilitation medicine
practitioners may have cognitive deficits, and these defi-
cits can range in severity from minor and subtle to signif-
icant and overt.
The population of patients who have suffered a traumatic
brain injury (TBI) is a good example. The severity of TBI
can range from mild to severe. Accordingly, persistent cog-
nitive deficits can range from mild and temporary to
severe and persistent. In cases of severe TBI, it may be
obvious that the patient does not have sufficient decision-
making capacity to be able to decide whether or not to
participate in a research protocol, and alternative arrange-
ments (such as proxy consent from a member of the fam-
ily) may have to be sought. In the case of more subtle
deficits, further capacity assessment may be required to
ascertain a particular individual's level of decision-making
ability.
Stroke is the most common diagnosis among patients in
most rehabilitation medicine programs [7]. Stroke
patients subsequently make up a large proportion of
potential research candidates, both as inpatients and out-
patients. Although a fairly significant number of stroke
patients may recover neurologically to the point where
they do not have any cognitive deficits which would inter-
fere with the decision-making process, many patients will
continue to have damage to the parts of the brain involved
in judgment and reasoning, and these patients might not
be able to make a truly informed decision regarding par-
ticipation in a research protocol. Again, if a concern exists,
the patient may need to undergo further capacity assess-
ment.
Two other populations frequently seen by rehabilitation
medicine practitioners are patients with multiple sclerosis
(MS) and those with Parkinson's disease (PD). These
patients often have very obvious physical impairments
and limitations (such as tremor, weakness and incoordi-
nation) that tend to receive the majority of medical and
therapeutic attention. However, a very significant propor-
tion of patients in each group will go on to develop cog-
nitive deficits that may affect decision-making capacity
but might be quite subtle unless specifically tested for
[8,9]. Both groups commonly develop what is termed a
subcortical-type dementia. Unlike the more common
Alzheimer's-type dementia, which manifests itself prima-
rily with deficits in memory and environmental aware-
ness, the deficits in subcortical dementias are less
apparent. These deficits often present as difficulties with
higher-level cognitive functions such as reasoning,
insight, judgment and abstraction. These difficulties, of
course, are relevant to capacity and may be present in a
degree sufficient to interfere with a patient's ability to
decide whether or not to participate in a research proto-
col, but unless specifically tested for, will not always be
apparent to the person obtaining informed consent.
There are many different types of patients seen by rehabil-
itation practitioners where decision-making capacity may
be of concern in the process of attempting to obtain
informed consent. Since it may be particularly difficult in
some of these cases to know whether a prospective subject
has adequately understood the relevant information and
appreciated the potential harms and benefits of participat-
ing, the researcher must be vigilant and willing to explore
any 'red flags' that may indicate lack of sufficient decision-
making capacity (arranging for a capacity assessment if
necessary) in order to ensure the participation of the sub-
ject is truly informed and voluntary.
Communication issues
In order to be able to consent to participate in a research
study, the potential subject must be able to understand
the nature and specific content of the protocol, as well as
the risks and benefits which are involved in participation.BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/2
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In order to be a subject, the patient will generally also
need to be able to communicate with the researcher. Both
these areas can be impaired in patients with language def-
icits.
The ability to use language to communicate with others,
be it in a written or verbal (or other) form, requires the
ability to comprehend information and to present infor-
mation to others in a form that they can understand.
Many patients in the rehabilitation population may have
varying degrees and types of aphasia.
If the language deficit involves comprehension, then
informed consent will obviously be difficult to obtain
from that particular subject, and they may have to be
excluded from the study, or proxy consent sought. For
patients with expressive deficits, they may be able to pro-
vide consent through non-verbal communication, but it
may be very difficult for them to participate in the
research protocol unless specific mechanisms are in place
to accommodate their deficits.
For example, some patients might substitute one word for
another when they attempt to express themselves. In some
cases the new word may be a nonsense word (or neolo-
gism) and it will be obvious to the researcher that the
answer is not valid. However, some patients will substi-
tute a true word, but one which has a different meaning
then they wish to express. Some patients will the use the
word "yes" in place of the word "no" because of their
aphasia, and this substitution will obviously have signifi-
cant repercussions on the ability of the researcher to
obtain valid and accurate data.
Therefore, in situations where a potential research subject
is thought to have aphasia, a thorough assessment should
be performed (usually by a Speech and Language Pathol-
ogist) to see if the patient is not only able to consent to
participation, but whether or not their communication
skills are sufficient to permit them to actually participate
in the study. In addition, where possible the Speech and
Language Pathologist could assist in facilitating the partic-
ipation of subjects who have certain specific communica-
tion impairments which might otherwise preclude them
from participating.
Timing of subject recruitment
Many patients who are admitted to a rehabilitation medi-
cine inpatient unit have had serious, and sometimes dev-
astating and life-altering, injuries or medical catastrophes.
Many of these patients need time to readjust to their new
station in life, and following an injury such as spinal cord
trauma, there is often a certain amount of grieving that
occurs for a part of the patient's life that may be lost to
them forever.
Within this setting, many subjects may be hesitant to
agree to participate in research projects as they are still try-
ing to cope with the new onset of a significant disability.
With time to readjust to the situation, many patients come
to view things differently, and go on to become willing
volunteers after they have had some time to heal both
physically and emotionally. Therefore, whenever possi-
ble, the researcher should take this into account, and
should try and approach the patient only after they have
had time to adjust to their new disability.
In fact, this adjustment may not occur while the person is
an inpatient (and sometimes, unfortunately, not at all),
and if this is the case, their participation in a potentially
time-consuming research protocol should probably not
be sought. This must be determined on an individual
basis, and may require discussion and consultation with
the patient's physician, the therapists involved, the
patient's family, and, whenever appropriate, the patient
themselves.
Another area where timing of research participation might
be an issue is in the TBI population. Because patients with
a brain injury often have complex cognitive and behavio-
ral deficits, they generally require in depth and ongoing
assessment of these issues. This assessment can be very
involved and complex and may take several weeks or
months, and the results obtained may have an impact in
terms of deciding whether or not the patient might be an
appropriate candidate for a research study.
However, many research studies and protocols require the
participation of the subject during their entire length of
stay on the rehabilitation ward, and some can continue
after the patient has been discharged back to the commu-
nity. Therefore, subject recruitment for a particular study
may be necessary before the completion (and sometimes
even the initiation) of in-depth cognitive and behavioral
assessments. The patient might thus be recruited to partic-
ipate before it is clear that they have the ability to consent
properly to such participation. There must be a balance
between the needs of the researchers to gather data
throughout the patient's stay and the right of the patient
to be protected from participating in a study when they do
not fully understand the risks and benefits of the research
in question. If there are concerns about decision-making
capacity, possible recruitment should be delayed until at
least an initial evaluation of capacity can be completed to
ensure that subjects are capable of consenting to partici-
pate.
The potential for overuse of individual subjects
The potential exists for individual subjects to be recruited
for multiple different studies at various times and thus
share a disproportionate burden for research participa-BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/2
Page 4 of 6
(page number not for citation purposes)
tion. This can be a concern especially in two particular sit-
uations in rehabilitation medicine. The first is the
situation where patients are residents of a particular facil-
ity for a long period of time and the second is when they
are members of a diagnostic group with relatively small
numbers of potential research subjects.
Although a large percentage of rehabilitation patients will
have a fairly short stay at an inpatient facility (weeks to
months), a smaller subset may be there for a longer period
of time, sometimes months to years. Some rehabilitation
programs may include long-term care beds where the
patient may be there for several years. When patients are
residents in a facility for a longer period of time, they may
be asked to participate in numerous research projects
undertaken by the same, or different, investigator(s) dur-
ing their stay. The longer the patient stays at that facility,
the more likely this is to occur.
Based on the ethical principle of justice, which examines
the distribution of costs and benefits of living in a society,
no one group should shoulder a disproportionate burden
of participation in research. For patients whose stay
exceeds a certain period of time, it might be reasonable to
have guidelines in place so that these patients will only be
asked to participate in a certain number of research
projects, perhaps one per year or one every two years, to
ensure they do not take on an excessive burden in this
area.
Within some diagnostic categories seen by the rehabilita-
tion medicine practitioner, there are relatively small
patient numbers. One example is the spinal cord injured
population. The incidence of spinal cord injury is approx-
imately 4 per 100000 per year [10], whereas the rate of
stroke is approximately 200 per 100000 per year or higher
[11]. This means that there are far fewer spinal cord
injured patients available to participate in research stud-
ies, and as a result the potential for subject overuse is quite
high in a population such as this. Many spinal cord
injured patients may be asked to participate in research
studies on the acute care neurosurgical ward, on the reha-
bilitation inpatient ward and later on after they have
returned to the community. Therefore, patients such as
these are at risk of agreeing to participate in a dispropor-
tionate number of studies when compared to patients in
other diagnostic categories, and of assuming an excessive
burden of research participation.
Hope for a cure
When a person becomes acutely ill, they depend on their
medical practitioner to arrive at a correct diagnosis and
formulate a treatment program that will restore them to
their previous state of health. Unfortunately, there are
some situations and diseases where no curative treatment
is currently available. This can be devastating information
for the patient and their family to receive, especially if the
illness or injury is severe or debilitating.
Within the diagnostic groups treated by the rehabilitation
specialist, there are many patients where curative treat-
ment is not available, and one can only try to manage the
symptoms and maximize functional ability. This includes,
but is not limited to, patients with spinal cord injuries and
multiple sclerosis.
The relatively recent occurrence of a spinal cord injury in
a well-known American movie actor has contributed to an
increased focus on research and the development of new
treatment options in this area. This has attracted increased
funding to assist those involved in spinal cord injury
research and has also contributed to the entrance of more
scientists to this particular field. Public statements and
appearances by this actor have given hope to many indi-
viduals who find themselves in similar situations, and
who previously may have held out no real hope for a cure.
Obviously, these are all very positive developments for
patients who have had an injury to their spinal cord.
However, there remains much work to be done in this
area, and although progress has certainly been made, we
are not yet necessarily on the cusp of a cure for spinal cord
injury. This is not always made clear to patients, who may
have been waiting a long time for even a small amount of
hope that they might someday walk again or regain the
use of their hands. When these patients are given the
opportunity to participate in a research trial, no matter
what the specific content of the trial, they may associate
the word "research" with "treatment" or "cure", even
when they may be told this is not the case.
There is therefore likely to be a greater probability of ther-
apeutic misconception in this group, because they have
suffered a devastating injury with no currently available
treatment, and because their hopes have been greatly
raised, fairly recently, for the prospect of a cure. The
researcher working with this population must be well
aware of this, and must endeavor to ensure that patients
truly understand the nature and potential outcomes of the
trial before they agree to consent to participate.
Patients with MS similarly have been faced with the diag-
nosis of a neurological disease for which there is no cure.
Although symptom management can be reasonably effec-
tive with this disease, life expectancy is reduced, and the
rate of disability and handicap is higher then in the back-
ground population. Recently, the development of medica-
tions which modulate the immune system, such as
interferons, has shown promise in certain subcategories of
the disease [12]. However, the results show a decreasedBMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/2
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number and severity of relapses of the disease, and not a
cure or total remission. Many patients with MS have diffi-
culty grasping these concepts, and have become desperate
for even a small amount of hope.
These patients, as well, are likely to agree to participate in
just about any type of research in the hope that it will pro-
vide some degree of benefit for them, even if they are told
this is not likely to be the case. As with spinal cord injured
patients, they often ask every time they come to the outpa-
tient clinic whether or not there are any research projects
under way that they can volunteer for, without any
prompting by the physician. Obviously, the potential for
therapeutic misconception is also quite high with this
group, and this needs to be considered and addressed by
the researcher.
Nature of the health care provider-research subject rela-
tionship
As discussed previously, many patients in the rehabilita-
tion medicine setting have recently had fairly serious inju-
ries or illnesses which have had a profound effect on their
lives and personal relationships. Within this setting, the
bond that develops between these patients and their
health care providers (such as physicians, nurses, and
therapists) can be exceptionally strong and powerful. Ini-
tially, the patient may be totally dependent on the mem-
bers of the care team for their self-care and bodily
integrity, and there is often a component of deep emo-
tional appreciation and gratitude for the care provided
during this period. As well, these patients are often on the
inpatient ward for a significant period of time, and the
relationship they have with members of their care team
often deepens and grows during this time.
Although patients in an acute care setting may experience
many of these feelings towards their health care providers,
it is often not as deep or as intense as the situation on the
rehabilitation medicine ward. In this setting, patients may
be more likely to agree to participate in a research project
out of a desire to please their health care team and because
they may perceive their participation as being one way
they can "repay" the kindness and care given to them by
the members of the team.
This means that the researcher must be especially careful
to ensure that the patient understands that their participa-
tion is entirely voluntary and that their refusal will not in
any way impact not just the quality of their health care,
but also their relationship with the members of their care
team. The researcher must ensure that the patient under-
stands they have every right to refuse to participate with-
out explanation and that they are free to withdraw from
the study at any point in time. Only after the researcher is
completely confident that these requirements have been
met should the patient be allowed to participate in the
study.
Summary
Various patient populations tend to present unique ethi-
cal issues and challenges to those doing research in these
areas. Many of these issues have been well discussed in
specialties such as pediatrics, obstetrics and medical
genetics. Although these challenges also exist in the field
of rehabilitation medicine, they have not been previously
defined or discussed.
This paper has attempted to identify areas of specific con-
cern when designing research protocols and recruiting
subjects for participation in studies in the rehabilitation
medicine setting. In some cases, recommendations are
provided to address these issues and concerns. It is clear
that more work and thought is required in this area to fur-
ther clarify these ethical issues and to ensure that the
rights of rehabilitation patients who participate in
research are recognized and respected.
Competing interests
None declared.
Author's contributions
Dr. Blackmer was responsible for identifying the topic,
reviewing the literature and preparing the manuscript, as
well as making applicable revisions.
Acknowledgements
The author wishes to thank Dr. Barbara Secker for her thoughtful com-
ments and constructive criticisms on the topic.
References
1. Harrison C, Kenny NP, Sidarous M and Rowell M: Involving chil-
dren in medical decisions CMAJ 1997, 156:825-828.
2. Annas GJ: Protecting the liberty of pregnant patients NEJM
1987, 316:1213-14.
3. Kolder VEB, Gallagher J and Parsons MT: Court-ordered obstetri-
cal interventions NEJM 1987, 316:1192-1196.
4. Lippman A: Prenatal diagnosis: Reproductive choice? Repro-
ductive control? In: The future of human reproduction Edited by: Over-
all C. Toronto, The Women's Press; 1989:182-194.
5. Burgess MM, Laberge CM and Knoppers BM: Ethics and genetics
in medicine CMAJ 1998, 158:1309-1313.
6. Etchells E, Sharpe G, Walsh P, Williams JR and Singer PA: Consent
CMAJ 1996, 155:177-180.
7. Roth EJ and Harvey RL: Rehabilitation of stroke syndromes In:
Physical Medicine and Rehabilitation 2nd edition. Edited by: Braddom RL.
Philadelphia, WB Saunders Co; 2000:1118.
8. Filley CM, Heaton RK, Nelson LM, Burks JS and Franklin GM: A com-
parison of dementia in Alzheimer's disease and multiple
sclerosis Arch Neurol 1989, 46:157-161.
9. Mortimer JA, Pirozzolo FJ, Hansch EC and Webster DD: Relation-
ship of motor symptoms to intellectual deficits in Parkin-
son's disease Neurology 1982, 32:133-137.
10. DeVivo MJ, Fine PR, Maetz HM and Stover SL: Prevalence of spinal
cord injury: re-estimation employing life table techniques
Arch Neurol 1980, 37:707-8.
11. Wolf PA, Kannez WB and Venter J: Current status of risk factors
for stroke Neurol Clin 1983, 1:317-343.
12. Shapiro RT: Medications used in the treatment of multiple
sclerosis Phys Med Rehabil Clin N Am 1999, 10:437-446.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/2
Page 6 of 6
(page number not for citation purposes)
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6939/4/2/prepub